The Effect of Omalizumab on Responses to Cat Allergen Challenge

NCT00604786 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Allergic Rhinitis

Interventions

DRUG: omalizumab
DRUG: placebo

Sponsor

Johns Hopkins University

Collaborators

[object Object]